51 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B Sell
Article Searches
One sector is beating tech this quarter, but one technician sees a ceiling https://www.cnbc.com/2018/08/31/one-sector-is-beating-tech-this-quarter-but-one-technician-sees-a-ceiling.html Aug 31, 2018 - One sector has been tearing up the S&P 500 this quarter, rocketing to new highs, and it's not tech. Health care has been the surprise winner as the third quarter enters the home stretch.
Allergan PLC (AGN) CEO Brent Saunders Presents at 2018 Wells Fargo Healthcare Conference (Transcript) https://seekingalpha.com/article/4204308-allergan-plc-agn-ceo-brent-saunders-presents-2018-wells-fargo-healthcare-conference?source=feed_sector_healthcare Sep 05, 2018 - Allergan PLC (NYSE:AGN) 2018 Wells Fargo Healthcare Conference Call September 05, 2018 09:05 AM ET Executives Brent Saunders - Chief Executive Officer Analysts David Maris - Wells Fargo Securities Pre
Top Insider Buys Highlight for the Week of Sept. 7 http://www.gurufocus.com/news/735552/top-insider-buys-highlight-for-the-week-of-sept-7 Sep 09, 2018 - Top Insider Buys Highlight for the Week of Sept. 7, Stocks: AXP,SLB,AGN,KDP, release date:Sep 07, 2018
Aceto 72% Target Net Gain Tops WallStar Healthcare Equities For September https://seekingalpha.com/article/4205864-aceto-72-percent-target-net-gain-tops-wallstar-healthcare-equities-september?source=feed_all_articles Sep 12, 2018 - But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare s
Your Daily Pharma Scoop: Alnylam Regains, Karyopharm Positive, Teva Approved https://seekingalpha.com/article/4206899-daily-pharma-scoop-alnylam-regains-karyopharm-positive-teva-approved?source=feed_sector_healthcare Sep 18, 2018 - Alnylam had an eventful week.Karyopharm reports positive Phase 2 data.Teva’s migraine drug is approved.
Urovant IPO: Phase 3 Clinical Data To Be Released In 2019 https://seekingalpha.com/article/4208614-urovant-ipo-phase-3-clinical-data-released-2019?source=feed_tag_ipo_analysis Sep 27, 2018 - Urovant is a clinical-stage biopharmaceutical company developing treatments for urologic conditions.The company is selling 10 million common shares at a price between $14.00 and $16.00 per common shar
Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA http://www.zacks.com/stock/news/325298/allergan-eyes-vraylar-label-expansion-fda-accepts-snda?cid=CS-ZC-FT-325298 Sep 27, 2018 - FDA accepts Allergan's (AGN) sNDA for label expansion of its schizophrenia drug, Vraylar (cariprazine) to include treatment of bipolar depression.
Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs http://www.zacks.com/stock/news/325440/pharma-stock-roundup-pfe-lly-get-approval-for-new-drugs-novartis-to-cut-jobs?cid=CS-ZC-FT-325440 Sep 28, 2018 - FDA grants approval to Lilly's (LLY) Emgality for migraine and Pfizer's (PFE) Vizimpro for an advanced lung cancer indication. Novartis (NVS) to cut more than 2,000 jobs in Switzerland and U.K
Paratek (PRTK) Gets FDA Approval for Nuzyra and Seysara http://www.zacks.com/stock/news/326044/paratek-prtk-gets-fda-approval-for-nuzyra-and-seysara?cid=CS-ZC-FT-326044 Oct 03, 2018 - Paratek (PRTK) gets FDA approval for Nuzyra for the treatment of serious community-acquired bacterial infections and Seysara for the treatment of acne.
VistaGen: Expensive At 12x Its Book Value Per Share https://seekingalpha.com/article/4210659-vistagen-expensive-12x-book-value-per-share?source=feed_sector_healthcare Oct 09, 2018 - VistaGen is a clinical-stage biopharmaceutical company developing treatments to fight depression and other central nervous system illnesses.With a large target market size and candidates at Phase 2 of

Pages: 123456

Page 1>

Related Companies

Name Exchange Price Mkt Cap
CELG Celgene Corporation NASDAQ $87.23 $61.35B
SHPG Shire plc NASDAQ $176.25 $46.08B
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $175.8 $44.93B
ZTS Zoetis Inc. NYSE $88.3 $42.55B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $386.665 $41.78B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Allergan plc.